北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 肿瘤化疗科  > 期刊论文
学科主题: 肿瘤学
题名:
抗体依赖细胞介导的细胞毒作用在利妥昔单抗耐药机制中的研究进展
其他题名: Research advances of antibody-dependent cell-mediated cytotoxicity in the resistance of rituximab
作者: 金璿
关键词: 淋巴瘤,非霍奇金 ; 利妥昔单抗 ; 耐药机制 ; 抗体依赖细胞介导细胞毒作用 ; Lymphoma,non-Hodgkin' ; s ; Rituximab ; Resistance mechanism ; Antibody-dependent cell-mediated cytotoxicity
刊名: 白血病·淋巴瘤
发表日期: 2013
DOI: 10.3760/cma.j.issn.1009-9921.2013.11.019
卷: 22, 期:11, 页:697-700
文章类型: Journal Article
摘要: 利妥昔单抗是一种在B细胞非霍奇金淋巴瘤(B-NHL)中广泛应用的单抗类靶向药物,作用于CD20抗原.其联合化疗显著改善了B细胞淋巴瘤患者的预后.但是仍有部分患者对利妥昔单抗治疗无效或在治疗有效后短期内复发,提示可能存在利妥昔单抗的耐药.利妥昔单抗对B细胞淋巴瘤细胞的杀伤机制主要包括直接诱导凋亡、抗体依赖细胞介导的细胞毒作用(ADCC)、补体依赖细胞毒作用(CDC)等,不同的作用机制可能存在不同的耐药机制,其中哪一种发挥了主要作用尚不明确.文章对利妥昔单抗ADCC作用机制中可能存在的影响疗效的因素进行综述. Rituximab,a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20,comparing with chemotherapy has significantly improved the treatment outcome of all subgroups of B-cell lymphoma patients.However,not all patients respond to rituximab plus chemotherapy or relapse in a short time after response,which suggests the existence of resistance mechanisms.Antibody-dependent cell-mediated cytotoxicity (ADCC) is one of the main mechanisms of rituximab,so any abnormalities in ADCC pathway may affect the efficacy of rituximab.With the widely application of rituximab,its resistance mechanisms are attracting more attention.This review will summarize the factors within ADCC pathway that may affect the antitumor effect of rituximab.
语种: 中文
原文出处: 查看原文
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/42314
Appears in Collections:北京大学第一临床医学院_肿瘤化疗科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 100034,北京大学第一医院肿瘤化疗科
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[金璿]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[金璿]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace